Citrus Sinensis ID: 006185


Local Sequence Feature Prediction

Prediction and (Method)Result
Residue Number Marker
Protein Sequence ?
Secondary Structure (PSIPRED) ?
Secondary Structure Prediction (SSPRO) ?
Coil and Loop (DISEMBL) ?
Flexible Loop (DISEMBL) ?
Low Complexity Region (SEG) ?
Disordered region (IsUnstruct) ?
Disordered Region (DISOPRED) ?
Disordered Region (DISEMBL) ?
Disordered Region (DISPRO) ?
Transmembrane Helix (TMHMM) ?
Transmembrane Helix (HMMTOP) ?
Transmembrane Helix (MEMSAT) ?
TM Helix, Signal Peptide (MEMSAT_SVM) ?
TM Helix, Signal Peptide (Phobius) ?
Signal Peptide (SignalP HMM Mode) ?
Signal Peptide (SignalP NN Mode) ?
Coiled Coils (COILS) ?
Positional Conservation ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600-------610-------620-------630-------640-------650-------
MRAGVELKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVSPPSSLSFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENFNKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGCLSNVKRLDVVGCGSMLKILPSHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANLGKKAAAEEMVLYRNRRYQIHIHATTSTSSPTPSLGNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQEIIMDDEGEVGLQGASTKKITFPSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGNQLTPKLLKGVEFGYCKYCWTGNLNHTIQQYVYNEKKIWEKQAMKSGISSGDYFL
ccccccccccccccccccccEEEEEcccccccccccccccccEEEccccccccccHHHHHccccccEEEccccccccccHHHHccccccEEEccccccccccccccccccccEEEccccccccccccccccccccEEcccccccccccccccccccccccEEEcccccccccccccHHHcccccHHcccccccccEEEEEcccccccccccccccccccEEEEcccccccHHHHHHHHcccccccccccccccccccccHHHHHHHcccccccccccccccccccccccccccccccEEEEEcccccEEEccccccccccccccccEEEcccccccEEcccccccccccccccEEEEEcccccccccccccccccccccEEEEcccccccccEEEcccccccccccccccccEEEccccccccccccccccccccccccEEEEccccccccccccccccccHHHHHHHcccccccccccccccccccccccccccEEEEEcccccccccccccccccccccEEEEEccccccccccccccccccccccccccccccccEEEcccccccccccccccccccccccccEEEccccccccccccccccccccEEEEEEEccEEccccccHHHHHHHHHHHHHHHHccccccccccccccc
ccccccccccccHHHHHccEEEEEccccHHHccccccccccEEEEEcccccccccHHHHHHccccEEEEccccccccccccHHHHHHccEEEccccccccccHHHHHHcccEEEEcccccHHHccHHHHHHHcccEEEcccccccccccHHHHHHHHcccEEEEccccccEcccccccccccccHHHHHccHcccEEEEEcccHcccccccccHHHccEEEEEcccccccccccccHHHccHHHHHHHHHccccccccccccHHHHHHcccEEEEcccccccccccccccccccccEEEEEccccccEEcccccccccccccccccEEEEcccHHHHHHccccccccccccccEEEEcccHcHcccccccHHcccccccEEEEcccccHHEEEcccccccccccccccccccEEEEcccccccHcccccccccccccccEEEEcccHHHHHccccccccHcccHHHHcccccccEcccHHcccccccccccccccEEEEcccccHHHcccHHHHHHHHcccEEEEcccHHHHHHEccccccHHHccccccccccccccEEEEccccccccccccccccccccccccEEEEEccccccEcccccccccHHcEEEEEccccccccccHHHHHHHHHHccHcccHccccccccccccccc
mragvelkdwpsintfedltgislmfndihevpdglecpkLQALFLqknhllvipdpffqgmkdlkvldlggirmvsppsslsflSNLRTLRLDYcnhlpdlsligelsgleildlsksdvneipvsfgrlshlrlldltdcynlelippgvLSRLRKLEELYMSHsfchwqfeseedtrsNAKFIELGALSRLtslhidipkgeimpsdmslpnltsfsitigeedtLNDFIELFLENFNKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEIchgqlpagclsnvkrldvvgcgsmlkilpsHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEkltlidlprmtdiwkgdTQFVSLHNLKKVRVEECDELRQVFPANLGKKAAAEEMVLYRNRRYQIHihattstssptpslgnlvsITIRGCGKLRNLFTTSMVKSLVRLeslevsscptlqeiimddegevglqgastkkitfpslfsiklcdlgsltcfsssglhATVEFLALEALqiidcpgmktfgygnqltpkllkgvefgyckycwtgnlnhTIQQYVYNEKKIWEKQAMksgissgdyfl
mragvelkdwpsinTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVSPPSSLSFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENFNKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGCLSNVKRLDVVGCGSMLKILPSHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRqvfpanlgkkaAAEEMVLYRNRRYQIHIhattstssptpslgNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQEIIMDDEGEVGLQGASTKKITFPSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGNQLTPKLLKGVEFGYCKYCWTGNLNHTIQQYVYNEKKIWEKQAmksgissgdyfl
MRAGVELKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVsppsslsflsNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENFNKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGCLSNVKRLDVVGCGSMLKILPSHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANLGKKAAAEEMVLYRNRRYQIHIHAttstssptpsLGNLVSITIRGCGKLRNLFTTSMVKslvrleslevssCPTLQEIIMDDEGEVGLQGASTKKITFPSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGNQLTPKLLKGVEFGYCKYCWTGNLNHTIQQYVYNEKKIWEKQAMKSGISSGDYFL
******LKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVSPPSSLSFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENFNKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGCLSNVKRLDVVGCGSMLKILPSHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANLGKKAAAEEMVLYRNRRYQIHIHATT*******SLGNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQEIIMDDEGEVGLQGASTKKITFPSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGNQLTPKLLKGVEFGYCKYCWTGNLNHTIQQYVYNEKKIWEK**************
**AGVELKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVSPPSSLSFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELI****LSRLRKLEELYMSHSFCHWQFESEE*****AKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENFNKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGCLSNVKRLDVVGCGSMLKILPSHLVQSFQNLQRLMVESCELLVSV**************LFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANL********MVLYRNRRYQIHIHA*TSTSSPTPSLGNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQEIIMD**************ITFPSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGNQLTPKLLKGVEFGYCKYCWTGNLNHTIQQYVYNEKKIWE***************
MRAGVELKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVSPPSSLSFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENFNKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGCLSNVKRLDVVGCGSMLKILPSHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANLGKKAAAEEMVLYRNRRYQIHIHATTSTSSPTPSLGNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQEIIMDDEGEVGLQGASTKKITFPSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGNQLTPKLLKGVEFGYCKYCWTGNLNHTIQQYVYNEKKIWEKQAMKSG********
****VELKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVSPPSSLSFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENFNKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGCLSNVKRLDVVGCGSMLKILPSHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANLGKKAAAEEMVLYRNRRYQIHIHATTSTSSPTPSLGNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQEIIMDDEGEV***GASTKKITFPSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGNQLTPKLLKGVEFGYCKYCWTGNLNHTIQQYVYNEKKIWEKQAMKSGISS***FL
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MRAGVELKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVSPPSSLSFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENFNKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGCLSNVKRLDVVGCGSMLKILPSHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANLGKKAAAEEMVLYRNRRYQIHIHATTSTSSPTPSLGNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQEIIMDDEGEVGLQGASTKKITFPSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGNQLTPKLLKGVEFGYCKYCWTGNLNHTIQQYVYNEKKIWEKQAMKSGISSGDYFL
no confident homologs detected

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST ?

ID ?Alignment graph ?Length ? Definition ? RBH(Q2H) ? RBH(H2Q) ? Q cover ? H cover ? Identity ? E-value ?
Query657 2.2.26 [Sep-21-2011]
O81825919 Probable disease resistan yes no 0.657 0.470 0.283 2e-21
Q9T048985 Disease resistance protei no no 0.336 0.224 0.342 5e-19
Q42484909 Disease resistance protei no no 0.525 0.379 0.250 5e-15
O64973889 Disease resistance protei no no 0.149 0.110 0.41 3e-10
Q940K0889 Probable disease resistan no no 0.179 0.132 0.335 4e-09
P60839884 Probable disease resistan no no 0.144 0.107 0.402 6e-09
Q6INV3238 Leucine-rich repeat-conta N/A no 0.210 0.579 0.326 9e-08
Q7KRY7 1851 Protein lap4 OS=Drosophil no no 0.222 0.078 0.316 1e-07
P60838894 Probable disease resistan no no 0.178 0.130 0.35 2e-07
Q24020 1256 Protein flightless-1 OS=D no no 0.197 0.103 0.358 3e-07
>sp|O81825|DRL28_ARATH Probable disease resistance protein At4g27220 OS=Arabidopsis thaliana GN=At4g27220 PE=2 SV=1 Back     alignment and function desciption
 Score =  104 bits (260), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 134/472 (28%), Positives = 206/472 (43%), Gaps = 40/472 (8%)

Query: 3   AGVELKDWPSINTFEDLTGISLMFNDIHEVPDG-LECPKLQALFLQKN-HLLVIPDPFFQ 60
           AG  L ++P       +  +SLM N +  +P+  +E  +   L LQ N H+  +P+ F Q
Sbjct: 456 AGRGLIEFPQDKFVSSVQRVSLMANKLERLPNNVIEGVETLVLLLQGNSHVKEVPNGFLQ 515

Query: 61  GMKDLKVLDLGGIRMVSPPSSLSFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSD 120
              +L++LDL G+R+ + P S S L +LR+L L  C  L +L  +  L  L+ LDL +S 
Sbjct: 516 AFPNLRILDLSGVRIRTLPDSFSNLHSLRSLVLRNCKKLRNLPSLESLVKLQFLDLHESA 575

Query: 121 VNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTR 180
           + E+P     LS LR + +++ Y L+ IP G + +L  LE L M+ S   W  + EE   
Sbjct: 576 IRELPRGLEALSSLRYICVSNTYQLQSIPAGTILQLSSLEVLDMAGSAYSWGIKGEE-RE 634

Query: 181 SNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENF 240
             A   E+  L  L  L I             L ++ SFS    E D+L   +  F   F
Sbjct: 635 GQATLDEVTCLPHLQFLAI------------KLLDVLSFSY---EFDSLTKRLTKFQFLF 679

Query: 241 NK-RCSRAMGLSQ------DMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDF 293
           +  R     G  +      D+ +S  ++ I  LL     L L     L  +F NL     
Sbjct: 680 SPIRSVSPPGTGEGCLAISDVNVS--NASIGWLLQHVTSLDLNYCEGLNGMFENLVTKSK 737

Query: 294 NELMFLYIFGCNEMKCL-LNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGC---L 349
           +  + +     +    L L S   +Q      LE L + +N N   I  G+L       L
Sbjct: 738 SSFVAMKALSIHYFPSLSLASGCESQLDLFPNLEELSL-DNVNLESI--GELNGFLGMRL 794

Query: 350 SNVKRLDVVGCGSMLKILPSH-LVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETELF 408
             +K L V GC  + ++     L  +  NLQ + V SC  L  +F    V +      L 
Sbjct: 795 QKLKLLQVSGCRQLKRLFSDQILAGTLPNLQEIKVVSCLRLEELFNFSSVPVDFCAESL- 853

Query: 409 SSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQV--FPANLG 458
             L KLT+I L  +  +       V L +L+ + VE C+ L+ +   P N G
Sbjct: 854 --LPKLTVIKLKYLPQLRSLCNDRVVLESLEHLEVESCESLKNLPFVPGNTG 903




Probable disease resistance protein.
Arabidopsis thaliana (taxid: 3702)
>sp|Q9T048|DRL27_ARATH Disease resistance protein At4g27190 OS=Arabidopsis thaliana GN=At4g27190 PE=2 SV=1 Back     alignment and function description
>sp|Q42484|RPS2_ARATH Disease resistance protein RPS2 OS=Arabidopsis thaliana GN=RPS2 PE=1 SV=1 Back     alignment and function description
>sp|O64973|RPS5_ARATH Disease resistance protein RPS5 OS=Arabidopsis thaliana GN=RPS5 PE=1 SV=2 Back     alignment and function description
>sp|Q940K0|DRL15_ARATH Probable disease resistance protein At1g61180 OS=Arabidopsis thaliana GN=At1g61180 PE=2 SV=2 Back     alignment and function description
>sp|P60839|DRL2_ARATH Probable disease resistance protein At1g12290 OS=Arabidopsis thaliana GN=At1g12290 PE=2 SV=1 Back     alignment and function description
>sp|Q6INV3|LRC57_XENLA Leucine-rich repeat-containing protein 57 OS=Xenopus laevis GN=lrrc57 PE=2 SV=1 Back     alignment and function description
>sp|Q7KRY7|LAP4_DROME Protein lap4 OS=Drosophila melanogaster GN=scrib PE=1 SV=1 Back     alignment and function description
>sp|P60838|DRL1_ARATH Probable disease resistance protein At1g12280 OS=Arabidopsis thaliana GN=At1g12280 PE=3 SV=1 Back     alignment and function description
>sp|Q24020|FLII_DROME Protein flightless-1 OS=Drosophila melanogaster GN=fliI PE=2 SV=1 Back     alignment and function description

Close Homologs in the Non-Redundant Database Detected by BLAST ?

GI ?Alignment Graph ?Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query657
224111296 1315 cc-nbs-lrr resistance protein [Populus t 0.876 0.438 0.334 1e-74
359494129 1144 PREDICTED: disease resistance protein At 0.907 0.520 0.333 3e-74
297735461 1063 unnamed protein product [Vitis vinifera] 0.799 0.493 0.346 2e-68
224111284 1340 cc-nbs-lrr resistance protein [Populus t 0.863 0.423 0.337 3e-68
147832986 975 hypothetical protein VITISV_010740 [Viti 0.799 0.538 0.342 7e-68
225445915 1063 PREDICTED: disease resistance protein At 0.797 0.492 0.347 9e-68
224143316 1337 cc-nbs-lrr resistance protein [Populus t 0.859 0.422 0.336 3e-66
255542484 2460 phosphoprotein phosphatase, putative [Ri 0.859 0.229 0.333 4e-65
297735460 1042 unnamed protein product [Vitis vinifera] 0.762 0.480 0.333 3e-63
359488103 1530 PREDICTED: disease resistance protein At 0.884 0.379 0.290 6e-61
>gi|224111296|ref|XP_002332952.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222834264|gb|EEE72741.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
 Score =  287 bits (735), Expect = 1e-74,   Method: Compositional matrix adjust.
 Identities = 203/607 (33%), Positives = 317/607 (52%), Gaps = 31/607 (5%)

Query: 6    ELKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQA-LFLQKNHLLVIPDPFFQGMKD 64
            E K+WP+ +  +  T ISL F  I ++P  LECP L + L L K+  L IPD FF+ MK+
Sbjct: 484  EFKEWPANDVLQQYTAISLPFRKIPDLPAILECPNLNSFLLLNKDPSLQIPDSFFREMKE 543

Query: 65   LKVLDLGGIRMVSPPSSLSFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEI 124
            LK+LDL  + +   PSSL FL NL+TL LD+C  L D+S+IGEL+ L++L L  S++  +
Sbjct: 544  LKILDLTEVNLSPLPSSLQFLENLQTLCLDHC-VLEDISIIGELNKLKVLSLMSSNIVRL 602

Query: 125  PVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAK 184
            P   G+++ L+LLDL++C  LE+I P  LS L +LE+LYM +SF  W+ E     R+NA 
Sbjct: 603  PREIGKVTRLQLLDLSNCERLEVISPNALSSLTRLEDLYMGNSFVKWETEGSSSQRNNAC 662

Query: 185  FIELGALSRLTSLHIDIPKGEIMPSDM--SLPNLTSFSITIGEEDTLNDFIELFLENFNK 242
              EL  LS L++LH+ I   + MP D+  S  NL  F I IG+          +  +   
Sbjct: 663  LSELKHLSNLSTLHMQITDADNMPKDLFSSFQNLERFRIFIGDG---------WDWSVKD 713

Query: 243  RCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIF 302
              SR + L  +  I  L   +  LL  +E L L E+N +++I ++L  + F +L  L++ 
Sbjct: 714  ATSRTLKLKLNTVIQ-LEEGVNTLLKITEELHLQELNGVKSILNDLDGEGFPQLRHLHVQ 772

Query: 303  GCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPAGCLSNVKRLDVVGCGS 362
             C  ++ ++NS+    R     L+ LF+    N  +ICHGQL A  L N++ L V  C  
Sbjct: 773  NCPGVQYIINSIRMGPRTAFLNLDSLFLENLDNLEKICHGQLMAESLGNLRILKVESCHR 832

Query: 363  MLKILPSHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEETEL--FSSLEKLTLIDLP 420
            +  +    + +    L+ + +  C+++  V   E  N A +   +  F+ L +LTL  LP
Sbjct: 833  LKNLFSVSMARRLVRLEEITIIDCKIMEEVVAEESENDAADGEPIIEFTQLRRLTLQCLP 892

Query: 421  RMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANLGKKAAA-EEMVLYRN----RRYQ 475
            + T       +       +K+   E      V    LG   +     +L+ N    +   
Sbjct: 893  QFTSFHSNVEESSDSQRRQKLLASEARSKEIVAGNELGTSMSLFNTKILFPNLEDLKLSS 952

Query: 476  IHIHAT--TSTSSPTPSLGNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQE 533
            I +        S  +P + NL SI +  C  L  L T+SMV+SL +L+ LE+ +C +++E
Sbjct: 953  IKVEKIWHDQPSVQSPCVKNLASIAVENCRNLNYLLTSSMVESLAQLKKLEICNCKSMEE 1012

Query: 534  IIM-DDEGEVGLQGASTKKITFPSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIID 592
            I++ +D GE    G    K+ FP L  + L  L  LT F +S L   +E  +L+ L + +
Sbjct: 1013 IVVPEDIGE----GKMMSKMLFPKLLILSLIRLPKLTRFCTSNL---LECHSLKVLTVGN 1065

Query: 593  CPGMKTF 599
            CP +K F
Sbjct: 1066 CPELKEF 1072




Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Class:

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359494129|ref|XP_002278428.2| PREDICTED: disease resistance protein At4g27190-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|297735461|emb|CBI17901.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
>gi|224111284|ref|XP_002332949.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222834261|gb|EEE72738.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|147832986|emb|CAN77367.1| hypothetical protein VITISV_010740 [Vitis vinifera] Back     alignment and taxonomy information
>gi|225445915|ref|XP_002263288.1| PREDICTED: disease resistance protein At4g27190-like [Vitis vinifera] Back     alignment and taxonomy information
>gi|224143316|ref|XP_002336027.1| cc-nbs-lrr resistance protein [Populus trichocarpa] gi|222838884|gb|EEE77235.1| cc-nbs-lrr resistance protein [Populus trichocarpa] Back     alignment and taxonomy information
>gi|255542484|ref|XP_002512305.1| phosphoprotein phosphatase, putative [Ricinus communis] gi|223548266|gb|EEF49757.1| phosphoprotein phosphatase, putative [Ricinus communis] Back     alignment and taxonomy information
>gi|297735460|emb|CBI17900.3| unnamed protein product [Vitis vinifera] Back     alignment and taxonomy information
>gi|359488103|ref|XP_002263579.2| PREDICTED: disease resistance protein At4g27190-like [Vitis vinifera] Back     alignment and taxonomy information

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST ?

ID ? Alignment graph ? Length ? Definition ? Q cover ? H cover ? Identity ? E-value ?
Query657
TAIR|locus:2131689919 AT4G27220 [Arabidopsis thalian 0.666 0.476 0.268 1.1e-22
TAIR|locus:2136447985 AT4G27190 [Arabidopsis thalian 0.637 0.425 0.260 2.3e-18
TAIR|locus:2201996889 RPS5 "AT1G12220" [Arabidopsis 0.240 0.177 0.345 4.5e-12
TAIR|locus:2034765884 AT1G12290 [Arabidopsis thalian 0.240 0.178 0.343 4.2e-10
TAIR|locus:2008440899 AT1G61180 [Arabidopsis thalian 0.203 0.149 0.358 5.3e-10
TAIR|locus:2005517909 RPS2 "RESISTANT TO P. SYRINGAE 0.441 0.319 0.254 8.9e-08
ZFIN|ZDB-GENE-080917-20 994 mfhas1 "malignant fibrous hist 0.232 0.153 0.306 1e-07
FB|FBgn0038504641 Sur-8 "Sur-8" [Drosophila mela 0.598 0.613 0.25 1.5e-07
TAIR|locus:2034770894 SUMM2 "AT1G12280" [Arabidopsis 0.248 0.182 0.323 1.7e-07
TAIR|locus:2091662 1424 AT3G14460 [Arabidopsis thalian 0.094 0.043 0.397 3.1e-07
TAIR|locus:2131689 AT4G27220 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
 Score = 296 (109.3 bits), Expect = 1.1e-22, P = 1.1e-22
 Identities = 125/466 (26%), Positives = 203/466 (43%)

Query:     3 AGVELKDWPSINTFEDLTGISLMFNDIHEVPDG-LECPKLQALFLQKN-HLLVIPDPFFQ 60
             AG  L ++P       +  +SLM N +  +P+  +E  +   L LQ N H+  +P+ F Q
Sbjct:   456 AGRGLIEFPQDKFVSSVQRVSLMANKLERLPNNVIEGVETLVLLLQGNSHVKEVPNGFLQ 515

Query:    61 GMKDLKVLDLGGIRMVXXXXXXXXXXNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSD 120
                +L++LDL G+R+           +LR+L L  C  L +L  +  L  L+ LDL +S 
Sbjct:   516 AFPNLRILDLSGVRIRTLPDSFSNLHSLRSLVLRNCKKLRNLPSLESLVKLQFLDLHESA 575

Query:   121 VNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTR 180
             + E+P     LS LR + +++ Y L+ IP G + +L  LE L M+ S   W  + EE   
Sbjct:   576 IRELPRGLEALSSLRYICVSNTYQLQSIPAGTILQLSSLEVLDMAGSAYSWGIKGEE-RE 634

Query:   181 SNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENF 240
               A   E+  L  L  L I +   +++       +LT   +T   +   +    +     
Sbjct:   635 GQATLDEVTCLPHLQFLAIKLL--DVLSFSYEFDSLTK-RLT-KFQFLFSPIRSVSPPGT 690

Query:   241 NKRCSRAMGLSQDMRIS-ALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFL 299
              + C   + +S D+ +S A   W   LL     L L     L  +F NL     +  + +
Sbjct:   691 GEGC---LAIS-DVNVSNASIGW---LLQHVTSLDLNYCEGLNGMFENLVTKSKSSFVAM 743

Query:   300 YIFGCNEMKCL-LNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLPA--GC-LSNVKRL 355
                  +    L L S   +Q      LE L + +N N   I  G+L    G  L  +K L
Sbjct:   744 KALSIHYFPSLSLASGCESQLDLFPNLEELSL-DNVNLESI--GELNGFLGMRLQKLKLL 800

Query:   356 DVVGCGSMLKILPSHLVQ-SFQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKL 414
              V GC  + ++    ++  +  NLQ + V SC  L  +F    V +   +    S L KL
Sbjct:   801 QVSGCRQLKRLFSDQILAGTLPNLQEIKVVSCLRLEELFNFSSVPV---DFCAESLLPKL 857

Query:   415 TLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQV--FPANLG 458
             T+I L  +  +       V L +L+ + VE C+ L+ +   P N G
Sbjct:   858 TVIKLKYLPQLRSLCNDRVVLESLEHLEVESCESLKNLPFVPGNTG 903




GO:0005634 "nucleus" evidence=ISM
GO:0006952 "defense response" evidence=IEA;ISS
GO:0043531 "ADP binding" evidence=IEA
TAIR|locus:2136447 AT4G27190 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2201996 RPS5 "AT1G12220" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2034765 AT1G12290 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2008440 AT1G61180 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2005517 RPS2 "RESISTANT TO P. SYRINGAE 2" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
ZFIN|ZDB-GENE-080917-20 mfhas1 "malignant fibrous histiocytoma amplified sequence 1" [Danio rerio (taxid:7955)] Back     alignment and assigned GO terms
FB|FBgn0038504 Sur-8 "Sur-8" [Drosophila melanogaster (taxid:7227)] Back     alignment and assigned GO terms
TAIR|locus:2034770 SUMM2 "AT1G12280" [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms
TAIR|locus:2091662 AT3G14460 [Arabidopsis thaliana (taxid:3702)] Back     alignment and assigned GO terms

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries ?

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server ?

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software ?

No EC number assignment, probably not an enzyme!


Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING ?

Your Input:
GSVIVG00027341001
SubName- Full=Chromosome chr19 scaffold_4, whole genome shotgun sequence; (963 aa)
(Vitis vinifera)
Predicted Functional Partners:
 
Sorry, there are no predicted associations at the current settings.
 

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query657
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 6e-07
COG4886394 COG4886, COG4886, Leucine-rich repeat (LRR) protei 7e-07
pfam1385560 pfam13855, LRR_8, Leucine rich repeat 2e-06
PLN00113968 PLN00113, PLN00113, leucine-rich repeat receptor-l 0.001
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
 Score = 46.4 bits (111), Expect = 6e-07
 Identities = 22/58 (37%), Positives = 31/58 (53%), Gaps = 2/58 (3%)

Query: 110 GLEILDLSKSDVNEIPV-SFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSH 166
            L+ LDLS + +  IP  +F  L +L++LDL+   NL  I P   S L  L  L +S 
Sbjct: 1   NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGN-NLTSISPEAFSGLPSLRSLDLSG 57


Length = 60

>gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat Back     alignment and domain information
>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information

Conserved Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query 657
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 100.0
PLN00113 968 leucine-rich repeat receptor-like protein kinase; 100.0
PLN032101153 Resistant to P. syringae 6; Provisional 99.93
PLN03210 1153 Resistant to P. syringae 6; Provisional 99.93
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.92
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.91
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.91
KOG4194 873 consensus Membrane glycoprotein LIG-1 [Signal tran 99.9
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.89
KOG0444 1255 consensus Cytoskeletal regulator Flightless-I (con 99.88
KOG0472565 consensus Leucine-rich repeat protein [Function un 99.87
KOG0618 1081 consensus Serine/threonine phosphatase 2C containi 99.87
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 99.76
KOG0617264 consensus Ras suppressor protein (contains leucine 99.72
KOG0617264 consensus Ras suppressor protein (contains leucine 99.71
KOG4341483 consensus F-box protein containing LRR [General fu 99.64
PRK15387788 E3 ubiquitin-protein ligase SspH2; Provisional 99.6
PRK15370754 E3 ubiquitin-protein ligase SlrP; Provisional 99.59
PRK15387788 E3 ubiquitin-protein ligase SspH2; Provisional 99.59
PRK15370754 E3 ubiquitin-protein ligase SlrP; Provisional 99.55
KOG4237498 consensus Extracellular matrix protein slit, conta 99.5
KOG4237498 consensus Extracellular matrix protein slit, conta 99.41
KOG4341483 consensus F-box protein containing LRR [General fu 99.4
KOG4658889 consensus Apoptotic ATPase [Signal transduction me 99.32
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 99.25
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.23
cd00116319 LRR_RI Leucine-rich repeats (LRRs), ribonuclease i 99.23
KOG0532722 consensus Leucine-rich repeat (LRR) protein, conta 99.18
PF14580175 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ 99.04
KOG0532722 consensus Leucine-rich repeat (LRR) protein, conta 98.99
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.95
COG4886394 Leucine-rich repeat (LRR) protein [Function unknow 98.95
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.91
KOG1259490 consensus Nischarin, modulator of integrin alpha5 98.89
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 98.64
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.59
PF1385561 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF 98.57
KOG3207505 consensus Beta-tubulin folding cofactor E [Posttra 98.56
PRK15386 426 type III secretion protein GogB; Provisional 98.54
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 98.54
PRK15386 426 type III secretion protein GogB; Provisional 98.47
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 98.44
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.44
KOG2120419 consensus SCF ubiquitin ligase, Skp2 component [Po 98.37
PLN03150623 hypothetical protein; Provisional 98.36
PLN03150623 hypothetical protein; Provisional 98.35
KOG0531414 consensus Protein phosphatase 1, regulatory subuni 98.35
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 98.34
KOG1909382 consensus Ran GTPase-activating protein [RNA proce 98.34
KOG1947482 consensus Leucine rich repeat proteins, some prote 98.23
KOG3665699 consensus ZYG-1-like serine/threonine protein kina 98.17
KOG3665699 consensus ZYG-1-like serine/threonine protein kina 98.16
KOG1947482 consensus Leucine rich repeat proteins, some prote 98.12
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.99
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.94
PF1279944 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_ 97.87
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 97.84
KOG1644233 consensus U2-associated snRNP A' protein [RNA proc 97.83
KOG1859 1096 consensus Leucine-rich repeat proteins [General fu 97.83
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 97.81
KOG4579177 consensus Leucine-rich repeat (LRR) protein associ 97.58
KOG2982418 consensus Uncharacterized conserved protein [Funct 97.52
KOG2982418 consensus Uncharacterized conserved protein [Funct 97.32
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 97.17
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.82
PF13306129 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_ 96.7
KOG2739260 consensus Leucine-rich acidic nuclear protein [Cel 96.68
KOG2123388 consensus Uncharacterized conserved protein [Funct 96.62
KOG2123388 consensus Uncharacterized conserved protein [Funct 96.36
COG5238388 RNA1 Ran GTPase-activating protein (RanGAP) involv 96.34
KOG3864221 consensus Uncharacterized conserved protein [Funct 96.23
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 95.94
KOG3864221 consensus Uncharacterized conserved protein [Funct 95.88
PF0056022 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Le 95.85
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 94.34
PF1350417 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OO 94.1
KOG0473326 consensus Leucine-rich repeat protein [Function un 93.21
KOG0473326 consensus Leucine-rich repeat protein [Function un 92.86
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 90.67
smart0037026 LRR Leucine-rich repeats, outliers. 90.67
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 89.14
smart0036926 LRR_TYP Leucine-rich repeats, typical (most popula 88.71
smart0037026 LRR Leucine-rich repeats, outliers. 88.71
smart0036726 LRR_CC Leucine-rich repeat - CC (cysteine-containi 87.4
KOG4308478 consensus LRR-containing protein [Function unknown 82.31
>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
Probab=100.00  E-value=6.4e-37  Score=355.19  Aligned_cols=513  Identities=19%  Similarity=0.209  Sum_probs=369.8

Q ss_pred             CCCccEEEccCCCccc-cCCCC-CCCCCcEEEecCCcCc-CCCchhhcCCCCccEEEecCCcCC-CCCccccCCCCCcEE
Q 006185           16 FEDLTGISLMFNDIHE-VPDGL-ECPKLQALFLQKNHLL-VIPDPFFQGMKDLKVLDLGGIRMV-SPPSSLSFLSNLRTL   91 (657)
Q Consensus        16 ~~~L~~L~l~~~~~~~-l~~~~-~~~~L~~L~l~~~~~~-~~~~~~~~~l~~Lr~L~L~~~~~~-~lp~~~~~l~~L~~L   91 (657)
                      ..+++.|++++|.++. ++..+ .+++|++|++++|.+. .+|..+|..+++||+|++++|++. .+|.  +.+++|++|
T Consensus        68 ~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~--~~l~~L~~L  145 (968)
T PLN00113         68 SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPR--GSIPNLETL  145 (968)
T ss_pred             CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCccCCcCChHHhccCCCCCEEECcCCccccccCc--cccCCCCEE
Confidence            3578899999998874 44444 8899999999999987 789888889999999999999885 4554  568899999


Q ss_pred             EccCCCCC-CCCcccCCCCCCCEEEeeCCCCC-cccccccCCCCCCEEEccCCCCCCCCchhHhhcCccCcEEEcccCcc
Q 006185           92 RLDYCNHL-PDLSLIGELSGLEILDLSKSDVN-EIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHSFC  169 (657)
Q Consensus        92 ~l~~~~~~-~~~~~~~~l~~L~~L~l~~~~i~-~lp~~i~~l~~L~~L~l~~c~~~~~~~~~~~~~l~~L~~L~l~~~~~  169 (657)
                      ++++|... ..|..++++++|++|++++|.+. .+|..++++++|++|++++|...+.+|.. ++++++|++|++++|.+
T Consensus       146 ~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~-l~~l~~L~~L~L~~n~l  224 (968)
T PLN00113        146 DLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRE-LGQMKSLKWIYLGYNNL  224 (968)
T ss_pred             ECcCCcccccCChHHhcCCCCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChH-HcCcCCccEEECcCCcc
Confidence            99999844 45788999999999999999876 78888999999999999997776777876 89999999999998865


Q ss_pred             ccccccccccccccchhhhcCCCCccEEEeecCCCc-cCCCC-CCCCCccEEEEEEcCccChhhHHHHHhhccc-ccCcc
Q 006185          170 HWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGE-IMPSD-MSLPNLTSFSITIGEEDTLNDFIELFLENFN-KRCSR  246 (657)
Q Consensus       170 ~~~~~g~~~~~~~~~~~~l~~l~~L~~L~l~~~~~~-~~~~~-~~l~~L~~L~l~~~~~~~~~~~~~~~~~~~~-~~~l~  246 (657)
                      ..           ..+..++++++|++|++++|... .+|.. ..+++|+.|++.++..      .+.++..+. ...++
T Consensus       225 ~~-----------~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l------~~~~p~~l~~l~~L~  287 (968)
T PLN00113        225 SG-----------EIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKL------SGPIPPSIFSLQKLI  287 (968)
T ss_pred             CC-----------cCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCEEECcCCee------eccCchhHhhccCcC
Confidence            42           56777889999999999998864 45544 6788999999886632      222233332 36788


Q ss_pred             eEEeecccchhhhHHHHHHHHccccEEEEeeccccccccccccccccccceEEEeecCCCceEEeecccccccccccccc
Q 006185          247 AMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERTQRVTLRKLE  326 (657)
Q Consensus       247 ~l~l~~~~~~~~l~~~~~~~~~~L~~L~L~~~~~l~~~~~~l~~~~~~~L~~L~l~~~~~l~~~~~~~~~~~~~~~~~L~  326 (657)
                      .+++++|.-...+|.++... ++|+.|++.++.-....+..+  ..+++|+.|++++|.-...++..     ...+++|+
T Consensus       288 ~L~Ls~n~l~~~~p~~~~~l-~~L~~L~l~~n~~~~~~~~~~--~~l~~L~~L~L~~n~l~~~~p~~-----l~~~~~L~  359 (968)
T PLN00113        288 SLDLSDNSLSGEIPELVIQL-QNLEILHLFSNNFTGKIPVAL--TSLPRLQVLQLWSNKFSGEIPKN-----LGKHNNLT  359 (968)
T ss_pred             EEECcCCeeccCCChhHcCC-CCCcEEECCCCccCCcCChhH--hcCCCCCEEECcCCCCcCcCChH-----HhCCCCCc
Confidence            88888875555677776665 889999998774322222222  34788999999888433333332     23478899


Q ss_pred             EEeccccccccccccccCCCC--CCCCccEEEEecCCCcccccchhHHHhcccCcEEEEcccccceeeeecccccccccc
Q 006185          327 WLFIRENQNFVEICHGQLPAG--CLSNVKRLDVVGCGSMLKILPSHLVQSFQNLQRLMVESCELLVSVFEIERVNIAKEE  404 (657)
Q Consensus       327 ~L~l~~~~~l~~~~~~~~~~~--~~~~L~~L~l~~c~~l~~~~p~~~~~~~~~L~~L~l~~c~~l~~~~~~~~~~~~~~~  404 (657)
                      .|+++++.     ..+..|..  .+++|+.|+++++. +....|..+ ..+++|+.|++++|.--..+         |..
T Consensus       360 ~L~Ls~n~-----l~~~~p~~~~~~~~L~~L~l~~n~-l~~~~p~~~-~~~~~L~~L~L~~n~l~~~~---------p~~  423 (968)
T PLN00113        360 VLDLSTNN-----LTGEIPEGLCSSGNLFKLILFSNS-LEGEIPKSL-GACRSLRRVRLQDNSFSGEL---------PSE  423 (968)
T ss_pred             EEECCCCe-----eEeeCChhHhCcCCCCEEECcCCE-ecccCCHHH-hCCCCCCEEECcCCEeeeEC---------Chh
Confidence            99998875     22233332  56788999998854 444455544 67889999999886533222         555


Q ss_pred             cccCCcccEEecCCCcCcccccCCCCcccccCCccEEEeccCcccccccccccccccchhhhhhhcccccceeecccccC
Q 006185          405 TELFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANLGKKAAAEEMVLYRNRRYQIHIHATTST  484 (657)
Q Consensus       405 ~~~~~~L~~L~l~~c~~L~~l~~~~~~~~~~~~L~~L~i~~C~~L~~~~~~~l~~~~~L~~l~l~~~~~l~~~~~~~~~~  484 (657)
                      +..+++|+.|+++++. ++...  +.....+++|++|++++|.-...+ |..+ ..++|+.|+++++       .+....
T Consensus       424 ~~~l~~L~~L~Ls~N~-l~~~~--~~~~~~l~~L~~L~L~~n~~~~~~-p~~~-~~~~L~~L~ls~n-------~l~~~~  491 (968)
T PLN00113        424 FTKLPLVYFLDISNNN-LQGRI--NSRKWDMPSLQMLSLARNKFFGGL-PDSF-GSKRLENLDLSRN-------QFSGAV  491 (968)
T ss_pred             HhcCCCCCEEECcCCc-ccCcc--ChhhccCCCCcEEECcCceeeeec-Cccc-ccccceEEECcCC-------ccCCcc
Confidence            6778889999998865 33221  122234788999999998654433 4433 3477888888764       233344


Q ss_pred             CCCCCCCCCccEEEEecCCCcceecccchhhcccCCcEEEEecCCCcceeeeCcCceecccCCCcceEeccccCeeEcCc
Q 006185          485 SSPTPSLGNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQEIIMDDEGEVGLQGASTKKITFPSLFSIKLCD  564 (657)
Q Consensus       485 ~~~~~~~~~L~~L~i~~c~~L~~l~~~~~~~~l~~L~~L~i~~C~~l~~~~~~~~~~~~l~~~~~~~~~~~~L~~L~l~~  564 (657)
                      |..+..+++|+.|++++|.-...+ |.. ...+++|++|++++|.--..++             .....+++|+.|++++
T Consensus       492 ~~~~~~l~~L~~L~Ls~N~l~~~~-p~~-~~~l~~L~~L~Ls~N~l~~~~p-------------~~~~~l~~L~~L~Ls~  556 (968)
T PLN00113        492 PRKLGSLSELMQLKLSENKLSGEI-PDE-LSSCKKLVSLDLSHNQLSGQIP-------------ASFSEMPVLSQLDLSQ  556 (968)
T ss_pred             ChhhhhhhccCEEECcCCcceeeC-ChH-HcCccCCCEEECCCCcccccCC-------------hhHhCcccCCEEECCC
Confidence            566778888999999887543333 333 4678899999998886433332             2223578899999999


Q ss_pred             CCCccccccCCCcceeeccccceeeeccCCCcceecCCC
Q 006185          565 LGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGN  603 (657)
Q Consensus       565 c~~l~~l~~~~~~~~~~~~sL~~L~i~~C~~l~~lp~~~  603 (657)
                      +.-...+| ....   .+++|+.|++++|+-...+|...
T Consensus       557 N~l~~~~p-~~l~---~l~~L~~l~ls~N~l~~~~p~~~  591 (968)
T PLN00113        557 NQLSGEIP-KNLG---NVESLVQVNISHNHLHGSLPSTG  591 (968)
T ss_pred             CcccccCC-hhHh---cCcccCEEeccCCcceeeCCCcc
Confidence            87666777 6666   57899999999998777777543



>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>PLN03210 Resistant to P Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] Back     alignment and domain information
>KOG0472 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional Back     alignment and domain information
>PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] Back     alignment and domain information
>KOG4341 consensus F-box protein containing LRR [General function prediction only] Back     alignment and domain information
>KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A Back     alignment and domain information
>KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>COG4886 Leucine-rich repeat (LRR) protein [Function unknown] Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A Back     alignment and domain information
>KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>PRK15386 type III secretion protein GogB; Provisional Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>KOG2120 consensus SCF ubiquitin ligase, Skp2 component [Posttranslational modification, protein turnover, chaperones] Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>PLN03150 hypothetical protein; Provisional Back     alignment and domain information
>KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG3665 consensus ZYG-1-like serine/threonine protein kinases [General function prediction only] Back     alignment and domain information
>KOG1947 consensus Leucine rich repeat proteins, some proteins contain F-box [General function prediction only] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>PF12799 LRR_4: Leucine Rich repeats (2 copies); PDB: 2OMT_A 1XEU_A 2OMX_A 2OMU_A 2UZY_A 2WQU_D 1D0B_A 2WQW_A 1OTO_A 2WQV_B Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG1644 consensus U2-associated snRNP A' protein [RNA processing and modification] Back     alignment and domain information
>KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG2982 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>PF13306 LRR_5: Leucine rich repeats (6 copies); PDB: 3ZYJ_A 3V47_B 3V44_A 3ZYN_A 3ZYO_A 3SB4_A Back     alignment and domain information
>KOG2739 consensus Leucine-rich acidic nuclear protein [Cell cycle control, cell division, chromosome partitioning; General function prediction only] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>KOG2123 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>COG5238 RNA1 Ran GTPase-activating protein (RanGAP) involved in mRNA processing and transport [Signal transduction mechanisms / RNA processing and modification] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>KOG3864 consensus Uncharacterized conserved protein [Function unknown] Back     alignment and domain information
>PF00560 LRR_1: Leucine Rich Repeat; InterPro: IPR001611 Leucine-rich repeats (LRR) consist of 2-45 motifs of 20-30 amino acids in length that generally folds into an arc or horseshoe shape [] Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>PF13504 LRR_7: Leucine rich repeat; PDB: 3OJA_B 3G06_A 1OOK_G 1QYY_G 1SQ0_B 1P9A_G 1GWB_A 1P8V_A 1M0Z_A 1U0N_D Back     alignment and domain information
>KOG0473 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>KOG0473 consensus Leucine-rich repeat protein [Function unknown] Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>smart00369 LRR_TYP Leucine-rich repeats, typical (most populated) subfamily Back     alignment and domain information
>smart00370 LRR Leucine-rich repeats, outliers Back     alignment and domain information
>smart00367 LRR_CC Leucine-rich repeat - CC (cysteine-containing) subfamily Back     alignment and domain information
>KOG4308 consensus LRR-containing protein [Function unknown] Back     alignment and domain information

Homologous Structure Templates

Structure Templates Detected by BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query657
3zyo_A411 Crystal Structure Of The N-Terminal Leucine Rich Re 8e-06
3zyn_A321 Crystal Structure Of The N-Terminal Leucine Rich Re 9e-06
3zyj_A440 Netring1 In Complex With Ngl1 Length = 440 1e-05
3zyi_A452 Netring2 In Complex With Ngl2 Length = 452 2e-04
>pdb|3ZYO|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats And Immunoglobulin Domain Of Netrin-G Ligand-3 Length = 411 Back     alignment and structure

Iteration: 1

Score = 48.9 bits (115), Expect = 8e-06, Method: Compositional matrix adjust. Identities = 55/162 (33%), Positives = 77/162 (47%), Gaps = 13/162 (8%) Query: 11 PSINTFEDLTGISLMFNDIHEVP-DGLE-CPKLQALFLQKNHLLVIPDPFFQGMKDLKVL 68 PS+NT E L N + VP E KL+ L+L+ N + IP F + L+ L Sbjct: 83 PSLNTLE------LFDNRLTTVPTQAFEYLSKLRELWLRNNPIESIPSYAFNRVPSLRRL 136 Query: 69 DLGGIRMVXXXXXXX--XXXNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEI-P 125 DLG ++ + NLR L L CN L D+ + L LE L+LS + ++ I P Sbjct: 137 DLGELKRLEYISEAAFEGLVNLRYLNLGMCN-LKDIPNLTALVRLEELELSGNRLDLIRP 195 Query: 126 VSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYMSHS 167 SF L+ LR L L + I L+ LEEL +SH+ Sbjct: 196 GSFQGLTSLRKLWLMHA-QVATIERNAFDDLKSLEELNLSHN 236
>pdb|3ZYN|A Chain A, Crystal Structure Of The N-Terminal Leucine Rich Repeats Of Netrin-G Ligand-3 Length = 321 Back     alignment and structure
>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1 Length = 440 Back     alignment and structure
>pdb|3ZYI|A Chain A, Netring2 In Complex With Ngl2 Length = 452 Back     alignment and structure

Structure Templates Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query657
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-25
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 5e-21
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 1e-13
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 1e-21
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 4e-14
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 5e-09
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-21
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-20
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 2e-09
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 2e-21
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 2e-17
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 2e-12
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 2e-06
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-21
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 1e-19
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 9e-18
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 2e-17
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 1e-07
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 4e-06
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 5e-21
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 7e-20
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 1e-08
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 7e-21
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 1e-13
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 1e-07
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 4e-20
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 2e-16
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 3e-16
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 5e-14
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 2e-12
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 4e-06
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 5e-20
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 2e-15
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 3e-15
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 1e-19
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 6e-19
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 7e-19
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 4e-07
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 5e-04
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 2e-19
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 5e-19
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-17
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 1e-14
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 5e-10
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 1e-18
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 2e-17
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 8e-15
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 9e-10
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 6e-09
3fxi_A605 TLR4, htoll, TOLL-like receptor 4; leucine rich re 4e-06
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 2e-18
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 5e-17
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 1e-16
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 4e-14
3jqh_A167 C-type lectin domain family 4 member M; DC-signr, 3e-07
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 2e-18
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 2e-16
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 4e-16
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 3e-12
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 5e-11
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 1e-17
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 2e-17
4fmz_A347 Internalin; leucine rich repeat, structural genomi 3e-17
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-16
4fmz_A347 Internalin; leucine rich repeat, structural genomi 2e-13
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 4e-17
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 6e-13
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 1e-16
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 6e-14
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 3e-13
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 5e-12
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 8e-04
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 2e-16
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 9e-15
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 9e-13
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 9e-12
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 4e-06
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 3e-16
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 8e-14
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 8e-16
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 2e-14
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 1e-10
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 7e-09
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 8e-16
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 2e-15
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 5e-13
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 1e-15
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 6e-12
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 2e-15
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 1e-11
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 6e-11
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 5e-09
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 3e-15
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 1e-04
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 3e-15
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 4e-12
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 1e-08
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 1e-14
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 9e-13
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 1e-05
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 2e-14
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 3e-14
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 8e-10
1o6v_A466 Internalin A; bacterial infection, extracellular r 2e-14
1o6v_A466 Internalin A; bacterial infection, extracellular r 3e-14
1o6v_A466 Internalin A; bacterial infection, extracellular r 5e-14
1o6v_A466 Internalin A; bacterial infection, extracellular r 6e-10
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 5e-14
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 5e-14
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 7e-14
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 2e-12
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 1e-10
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 7e-14
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 1e-13
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 8e-14
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 6e-13
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 4e-09
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 4e-09
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 2e-13
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 3e-13
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 3e-11
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 5e-11
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 5e-11
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 5e-11
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 6e-09
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 3e-06
3rgz_A 768 Protein brassinosteroid insensitive 1; phytohormon 3e-04
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-13
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 3e-13
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-12
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 2e-10
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 2e-13
1vt4_I 1221 APAF-1 related killer DARK; drosophila apoptosome, 3e-09
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 7e-13
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 5e-12
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 5e-09
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 8e-05
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 8e-13
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 1e-11
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 1e-12
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 3e-11
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 4e-11
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 1e-08
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 6e-12
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 6e-10
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 5e-08
4ezg_A197 Putative uncharacterized protein; internalin-A, le 8e-12
4ezg_A197 Putative uncharacterized protein; internalin-A, le 1e-09
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 3e-11
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 8e-04
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 1e-10
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 6e-10
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 1e-09
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 4e-10
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 5e-09
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 1e-06
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 4e-05
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 1e-09
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 9e-09
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 1e-05
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 1e-09
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 3e-07
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 3e-05
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 2e-09
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 3e-08
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 5e-07
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 4e-09
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 7e-09
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 5e-07
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 5e-09
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 5e-07
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 2e-04
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 7e-09
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 5e-07
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 2e-08
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 2e-04
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 3e-04
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 8e-08
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 4e-04
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 1e-07
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 2e-04
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 3e-07
3e6j_A229 Variable lymphocyte receptor diversity region; var 5e-07
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 2e-06
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 7e-06
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 5e-05
3m19_A251 Variable lymphocyte receptor A diversity region; a 2e-06
3m19_A251 Variable lymphocyte receptor A diversity region; a 4e-06
3m19_A251 Variable lymphocyte receptor A diversity region; a 9e-06
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 2e-06
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 1e-04
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 6e-06
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 2e-05
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 4e-04
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 4e-05
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 2e-04
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 6e-05
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 2e-04
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
 Score =  110 bits (278), Expect = 1e-25
 Identities = 73/427 (17%), Positives = 140/427 (32%), Gaps = 57/427 (13%)

Query: 23  SLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVS-PPSS 81
                    +P GL    +++L L  N +  I     +   +L+VL L   R+ +    +
Sbjct: 11  DGRSRSFTSIPSGL-TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDA 69

Query: 82  LSFLSNLRTLRLDYCNHLPDLS--LIGELSGLEILDLSKSDVNEIPVS--FGRLSHLRLL 137
              L +L  L L   NHL  LS    G LS L+ L+L  +    + V+  F  L++L+ L
Sbjct: 70  FYSLGSLEHLDLSD-NHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTL 128

Query: 138 DLTDCYNLELIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSL 197
            + +      I     + L  L EL +          +           +  +L  +  +
Sbjct: 129 RIGNVETFSEIRRIDFAGLTSLNELEIKAL----SLRN----------YQSQSLKSIRDI 174

Query: 198 HIDIPKGEIMPSDMSLPNLTSFSITIGEEDTLNDFIELFLENFNKRCSRAMGLSQDMRIS 257
           H            + L             D L+    L L + N    +   L  D   S
Sbjct: 175 HH---------LTLHLSESAFLLEIFA--DILSSVRYLELRDTNLARFQFSPLPVDEVSS 223

Query: 258 ALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFLYIFGCNEMKCLLNSLERT 317
            +        + ++  +  E+  L      L+  +F++     +   N      + +   
Sbjct: 224 PMKKLAFRGSVLTD-ESFNELLKLLRYILELSEVEFDDCTLNGLGDFN--PSESDVVSEL 280

Query: 318 QRVTLRKLEWLFIRENQNFVEICHGQLPAGC---LSNVKRLDVVGCGSMLKILPSHLVQS 374
            +V    +  L I +   F         +     L  VKR+ V      + ++P    Q 
Sbjct: 281 GKVETVTIRRLHIPQFYLF------YDLSTVYSLLEKVKRITVENSK--VFLVPCSFSQH 332

Query: 375 FQNLQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKLTLIDLP--RMTDIWKGDTQF 432
            ++L+ L +    +         V    + +    +   L  + L    +  + K     
Sbjct: 333 LKSLEFLDLSENLM---------VEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEIL 383

Query: 433 VSLHNLK 439
           ++L NL 
Sbjct: 384 LTLKNLT 390


>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Length = 336 Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 Back     alignment and structure

Structure Templates Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query657
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
3rgz_A768 Protein brassinosteroid insensitive 1; phytohormon 100.0
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 100.0
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
1ziw_A680 TOLL-like receptor 3; innate immunity, immune syst 100.0
3vq2_A606 TLR4, TOLL-like receptor 4; leucine rich repeat MD 100.0
3t6q_A606 CD180 antigen; protein-protein complex, leucine ri 100.0
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 100.0
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 100.0
2z63_A570 TOLL-like receptor 4, variable lymphocyte recepto; 100.0
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 100.0
2z81_A549 CD282 antigen, TOLL-like receptor 2, variable lymp 100.0
3j0a_A 844 TOLL-like receptor 5; membrane protein, leucine-ri 100.0
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 100.0
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.97
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.97
4eco_A636 Uncharacterized protein; leucine-rich repeats, pro 99.97
2z7x_B520 TOLL-like receptor 1, variable lymphocyte recepto; 99.97
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.97
4ecn_A876 Leucine-rich repeat protein; leucine-rich repeats, 99.97
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.97
4g8a_A635 TOLL-like receptor 4; leucine rich repeat MD-2 rel 99.96
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.96
1o6v_A466 Internalin A; bacterial infection, extracellular r 99.95
3a79_B562 TLR6, VLRB.59, TOLL-like receptor 6, variable lymp 99.95
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.95
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.95
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.94
4fmz_A347 Internalin; leucine rich repeat, structural genomi 99.94
3v47_A455 TOLL-like receptor 5B and variable lymphocyte REC 99.94
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.94
1jl5_A454 Outer protein YOPM; leucine-rich repeat, molecular 99.94
3bz5_A457 Internalin-J, INLJ; leucine rich repeat (LRR), cys 99.94
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.94
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.93
2id5_A477 Lingo-1, leucine rich repeat neuronal 6A; CNS-spec 99.93
3o6n_A390 APL1; leucine-rich repeat, protein binding; HET: N 99.92
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 99.92
3oja_B597 Anopheles plasmodium-responsive leucine-rich REPE 99.91
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.89
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.89
1xku_A330 Decorin; proteoglycan, leucine-rich repeat, struct 99.89
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.89
2ft3_A332 Biglycan; proteoglycan, dimer interface, structura 99.89
3ogk_B592 Coronatine-insensitive protein 1; leucine rich rep 99.88
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.88
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.87
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.87
4fcg_A328 Uncharacterized protein; structural genomics, PSI- 99.87
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.87
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.87
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.86
2z80_A353 TOLL-like receptor 2, variable lymphocyte recepto; 99.85
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.85
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.85
2p1m_B594 Transport inhibitor response 1 protein; F-BOX, leu 99.84
1ozn_A285 Reticulon 4 receptor; NOGO receptor, MAD, myelinat 99.84
1ogq_A313 PGIP-2, polygalacturonase inhibiting protein; inhi 99.84
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.84
3zyj_A440 Leucine-rich repeat-containing protein 4C; cell ad 99.84
3zyi_A452 Leucine-rich repeat-containing protein 4; cell adh 99.84
2z66_A306 Variable lymphocyte receptor B, TOLL-like recepto; 99.83
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.83
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.83
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.82
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.82
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.82
3g06_A622 SSPH2 (leucine-rich repeat protein); E3 ubiquitin 99.81
2o6q_A270 Variable lymphocyte receptor A; leucine-rich repea 99.81
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.81
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.81
1h6u_A308 Internalin H; cell adhesion, leucine rich repeat, 99.8
1z7x_W461 Ribonuclease inhibitor; leucine-rich repeat, enzym 99.79
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.78
1p9a_G290 Platelet glycoprotein IB alpha chain precursor; pl 99.78
3rfs_A272 Internalin B, repeat modules, variable lymphocyte 99.78
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.77
3o53_A317 Protein LRIM1, AGAP006348-PA; leucine-rich repeat, 99.76
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.76
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.75
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.75
2z62_A276 TOLL-like receptor 4, variable lymphocyte recepto; 99.75
2xwt_C239 Thyrotropin receptor; signaling protein-immune sys 99.75
3m19_A251 Variable lymphocyte receptor A diversity region; a 99.74
1wwl_A312 Monocyte differentiation antigen CD14; LPS, immune 99.74
1h6t_A291 Internalin B; cell adhesion, leucine rich repeat, 99.72
3oja_A487 Leucine-rich immune molecule 1; coiled-coil, helix 99.72
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 99.71
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.7
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.68
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.68
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.68
1xeu_A263 Internalin C; cellular invasion, leucine-rich repe 99.68
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.67
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.67
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.67
2o6s_A208 Variable lymphocyte receptor B; leucine-rich repea 99.67
4ezg_A197 Putative uncharacterized protein; internalin-A, le 99.66
1m9s_A605 Internalin B; cell invasion, GW domains, SH3 domai 99.66
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.64
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.64
4glp_A310 Monocyte differentiation antigen CD14; alpha beta 99.63
2xot_A361 Amphoterin-induced protein 1; cell adhesion, neuro 99.63
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 99.62
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.62
3e6j_A229 Variable lymphocyte receptor diversity region; var 99.61
4ay9_X350 Follicle-stimulating hormone receptor; hormone-rec 99.61
3cvr_A571 Invasion plasmid antigen; leucine rich repeat and 99.61
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.6
2v9t_B220 SLIT homolog 2 protein N-product; structural prote 99.59
2ast_B336 S-phase kinase-associated protein 2; SCF-substrate 99.59
2v70_A220 SLIT-2, SLIT homolog 2 protein N-product; neurogen 99.58
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.58
2ca6_A386 RAN GTPase-activating protein 1; GAP, GTPase activ 99.58
3goz_A362 Leucine-rich repeat-containing protein; LEGL7, NES 99.55
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.55
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.52
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.51
2ell_A168 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.5
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.49
2je0_A149 Acidic leucine-rich nuclear phosphoprotein 32 FAM 99.47
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.46
1a9n_A176 U2A', U2A'; complex (nuclear protein/RNA), RNA, sn 99.46
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.45
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.44
2wfh_A193 SLIT homolog 2 protein C-product; developmental pr 99.43
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 99.42
1w8a_A192 SLIT protein; signaling protein, secreted protein, 99.41
4b8c_D727 Glucose-repressible alcohol dehydrogenase transcr 99.39
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 99.35
2o6r_A177 Variable lymphocyte receptor B; leucine-rich repea 99.34
1dce_A567 Protein (RAB geranylgeranyltransferase alpha subun 99.31
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 99.28
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.26
1ds9_A198 Outer arm dynein; leucine-rich repeat, beta-BETA-a 99.24
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 99.22
2r9u_A174 Variable lymphocyte receptor; adaptive immunity, V 99.16
3g39_A170 Variable lymphocyte receptor VLRB.2D; antibody, X- 99.13
3sb4_A329 Hypothetical leucine rich repeat protein; LRR, rig 99.08
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.98
4fdw_A401 Leucine rich hypothetical protein; putative cell s 98.98
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 98.88
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 98.85
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.85
4fs7_A394 Uncharacterized protein; leucine-rich repeats, pro 98.84
3un9_A372 NLR family member X1; leucine rich repeat (LRR), a 98.79
2ifg_A347 High affinity nerve growth factor receptor; TRK, T 98.77
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.54
3e4g_A176 ATP synthase subunit S, mitochondrial; leucine-ric 98.51
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 98.38
2ra8_A362 Uncharacterized protein Q64V53_bacfr; WGR domain, 98.35
4gt6_A394 Cell surface protein; leucine rich repeats, putati 98.34
4gt6_A394 Cell surface protein; leucine rich repeats, putati 98.14
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 97.99
1io0_A185 Tropomodulin; LRR protein, right-handed super-heli 97.97
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.81
3rw6_A267 Nuclear RNA export factor 1; retroviral constituti 97.66
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 97.66
4h09_A379 Hypothetical leucine rich repeat protein; two LRR_ 96.89
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 96.6
3rfe_A130 Platelet glycoprotein IB beta chain; platelet surf 94.7
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 94.44
1pgv_A197 TMD-1, tropomodulin TMD-1; structural genomics, PS 94.33
>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
Probab=100.00  E-value=1.2e-41  Score=383.29  Aligned_cols=575  Identities=17%  Similarity=0.097  Sum_probs=348.9

Q ss_pred             CCCCCCCccEEEccCCCcc-ccCC--CC-CCCCCcEEEecCCcCc-CCCchhhcCCCCccEEEecCCcCCC-CCcc---c
Q 006185           12 SINTFEDLTGISLMFNDIH-EVPD--GL-ECPKLQALFLQKNHLL-VIPDPFFQGMKDLKVLDLGGIRMVS-PPSS---L   82 (657)
Q Consensus        12 ~~~~~~~L~~L~l~~~~~~-~l~~--~~-~~~~L~~L~l~~~~~~-~~~~~~~~~l~~Lr~L~L~~~~~~~-lp~~---~   82 (657)
                      .+..+++|++|++++|.++ .+|.  .+ .+++|++|++++|.+. .+|..++.++++|++|++++|.++. .|..   +
T Consensus        95 ~~~~l~~L~~L~Ls~n~l~~~~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~~~~~l~~L~~L~Ls~n~l~~~~~~~~~~~  174 (768)
T 3rgz_A           95 GFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLS  174 (768)
T ss_dssp             CCCCCTTCCEEECCSSEEEEEGGGGGGGGGCTTCCEEECCSSEEECCSSCCSCCCCTTCSEEECCSSCCEEETHHHHHHT
T ss_pred             hhccCCCCCEEECCCCcCCCcCCChHHHhCCCCCCEEECcCCccCCcCCHHHhccCCCCCEEECCCCccCCcCChhhhhh
Confidence            6888999999999999987 5665  44 8899999999999877 5565555788999999999998864 3344   6


Q ss_pred             cCCCCCcEEEccCCCCCCCCcccCCCCCCCEEEeeCCCCCcccccccCCCCCCEEEccCCCCCCCCchhHhhcCccCcEE
Q 006185           83 SFLSNLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEEL  162 (657)
Q Consensus        83 ~~l~~L~~L~l~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~lp~~i~~l~~L~~L~l~~c~~~~~~~~~~~~~l~~L~~L  162 (657)
                      .++++|++|++++|. +.....++++++|++|++++|.++..+..++++++|++|++++|...+.+|.. ++++++|++|
T Consensus       175 ~~l~~L~~L~Ls~n~-l~~~~~~~~l~~L~~L~Ls~n~l~~~~~~l~~l~~L~~L~Ls~n~l~~~~~~~-l~~l~~L~~L  252 (768)
T 3rgz_A          175 DGCGELKHLAISGNK-ISGDVDVSRCVNLEFLDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRA-ISTCTELKLL  252 (768)
T ss_dssp             TCCTTCCEEECCSSE-EESCCBCTTCTTCCEEECCSSCCCSCCCBCTTCCSCCEEECCSSCCCSCHHHH-TTTCSSCCEE
T ss_pred             ccCCCCCEEECCCCc-ccccCCcccCCcCCEEECcCCcCCCCCcccccCCCCCEEECcCCcCCCcccHH-HhcCCCCCEE
Confidence            788888888888887 33333447788888888888887754444888888888888886544455554 7788888888


Q ss_pred             EcccCccccccccccccccccchhhhcCCCCccEEEeecCCCc-cCCCC-CC-CCCccEEEEEEcCcc-Chhh-------
Q 006185          163 YMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGE-IMPSD-MS-LPNLTSFSITIGEED-TLND-------  231 (657)
Q Consensus       163 ~l~~~~~~~~~~g~~~~~~~~~~~~l~~l~~L~~L~l~~~~~~-~~~~~-~~-l~~L~~L~l~~~~~~-~~~~-------  231 (657)
                      ++++|.+..           ..+.  ..+++|++|++++|.+. .+|.. .. +++|+.|++.++... ..+.       
T Consensus       253 ~Ls~n~l~~-----------~~~~--~~l~~L~~L~L~~n~l~~~ip~~~~~~~~~L~~L~Ls~n~l~~~~p~~~~~l~~  319 (768)
T 3rgz_A          253 NISSNQFVG-----------PIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSL  319 (768)
T ss_dssp             ECCSSCCEE-----------SCCC--CCCTTCCEEECCSSEEEESCCCCSCTTCTTCSEEECCSSEEEECCCGGGGGCTT
T ss_pred             ECCCCcccC-----------ccCc--cccCCCCEEECcCCccCCccCHHHHhhcCcCCEEECcCCcCCCccchHHhcCCC
Confidence            888775432           1111  14445555555555442 33333 11 244555544433210 0000       


Q ss_pred             ----------HHHHHhhc-c-cccCcceEEeecccchhhhHHHHHHHHccccEEEEeeccccccccccccccccccceEE
Q 006185          232 ----------FIELFLEN-F-NKRCSRAMGLSQDMRISALHSWIKNLLLRSEILALIEVNDLENIFSNLANDDFNELMFL  299 (657)
Q Consensus       232 ----------~~~~~~~~-~-~~~~l~~l~l~~~~~~~~l~~~~~~~~~~L~~L~L~~~~~l~~~~~~l~~~~~~~L~~L  299 (657)
                                +.+.++.. + ..+.++.++++++.-...+|.++....++|+.|+++++.-....++.+....+++|++|
T Consensus       320 L~~L~L~~n~l~~~ip~~~l~~l~~L~~L~Ls~n~l~~~~p~~l~~l~~~L~~L~Ls~N~l~~~~~~~~~~~~~~~L~~L  399 (768)
T 3rgz_A          320 LESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQEL  399 (768)
T ss_dssp             CCEEECCSSEEEEECCHHHHTTCTTCCEEECCSSEEEECCCTTHHHHTTTCSEEECCSSEEEEECCTTTTCSTTCCCCEE
T ss_pred             ccEEECCCCcccCcCCHHHHhcCCCCCEEeCcCCccCccccHHHHhhhcCCcEEEccCCCcCCCcChhhhhcccCCccEE
Confidence                      11111111 1 22555666666553333455555554236666666655322222223222235667777


Q ss_pred             EeecCCCceEEeeccccccccccccccEEeccccccccccccccCC--CCCCCCccEEEEecCCCcccccchhHHHhccc
Q 006185          300 YIFGCNEMKCLLNSLERTQRVTLRKLEWLFIRENQNFVEICHGQLP--AGCLSNVKRLDVVGCGSMLKILPSHLVQSFQN  377 (657)
Q Consensus       300 ~l~~~~~l~~~~~~~~~~~~~~~~~L~~L~l~~~~~l~~~~~~~~~--~~~~~~L~~L~l~~c~~l~~~~p~~~~~~~~~  377 (657)
                      ++++| .+......    ....+++|+.|++++|. +    .+..|  .+.+++|+.|++++|. +.+..|..+ ..+++
T Consensus       400 ~L~~n-~l~~~~p~----~l~~l~~L~~L~Ls~N~-l----~~~~p~~l~~l~~L~~L~L~~n~-l~~~~p~~~-~~l~~  467 (768)
T 3rgz_A          400 YLQNN-GFTGKIPP----TLSNCSELVSLHLSFNY-L----SGTIPSSLGSLSKLRDLKLWLNM-LEGEIPQEL-MYVKT  467 (768)
T ss_dssp             ECCSS-EEEEECCG----GGGGCTTCCEEECCSSE-E----ESCCCGGGGGCTTCCEEECCSSC-CCSCCCGGG-GGCTT
T ss_pred             ECCCC-ccccccCH----HHhcCCCCCEEECcCCc-c----cCcccHHHhcCCCCCEEECCCCc-ccCcCCHHH-cCCCC
Confidence            77777 33322211    23357788888888775 2    22233  2367788888888864 443355544 56788


Q ss_pred             CcEEEEcccccceeeeecccccccccccccCCcccEEecCCCcCcccccCCCCcccccCCccEEEeccCccccccccccc
Q 006185          378 LQRLMVESCELLVSVFEIERVNIAKEETELFSSLEKLTLIDLPRMTDIWKGDTQFVSLHNLKKVRVEECDELRQVFPANL  457 (657)
Q Consensus       378 L~~L~l~~c~~l~~~~~~~~~~~~~~~~~~~~~L~~L~l~~c~~L~~l~~~~~~~~~~~~L~~L~i~~C~~L~~~~~~~l  457 (657)
                      |++|+++++.-...+         |..+..+++|+.|++++|.--..+   +.....+++|++|++++|. ++...|..+
T Consensus       468 L~~L~L~~N~l~~~~---------p~~l~~l~~L~~L~L~~N~l~~~~---p~~~~~l~~L~~L~L~~N~-l~~~~p~~l  534 (768)
T 3rgz_A          468 LETLILDFNDLTGEI---------PSGLSNCTNLNWISLSNNRLTGEI---PKWIGRLENLAILKLSNNS-FSGNIPAEL  534 (768)
T ss_dssp             CCEEECCSSCCCSCC---------CGGGGGCTTCCEEECCSSCCCSCC---CGGGGGCTTCCEEECCSSC-CEEECCGGG
T ss_pred             ceEEEecCCcccCcC---------CHHHhcCCCCCEEEccCCccCCcC---ChHHhcCCCCCEEECCCCc-ccCcCCHHH
Confidence            888888875432222         556677888888888887533233   2334557888888888874 444457778


Q ss_pred             ccccchhhhhhhccccccee------------------------------------------------------------
Q 006185          458 GKKAAAEEMVLYRNRRYQIH------------------------------------------------------------  477 (657)
Q Consensus       458 ~~~~~L~~l~l~~~~~l~~~------------------------------------------------------------  477 (657)
                      +.+++|+.|+++++.-....                                                            
T Consensus       535 ~~l~~L~~L~Ls~N~l~g~ip~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  614 (768)
T 3rgz_A          535 GDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCN  614 (768)
T ss_dssp             GGCTTCCEEECCSSEEESBCCGGGGTTTTCBCCSTTCSCEEEEEECCSCCTTCCSSEEEEECTTCCGGGGGGGGGTCCSC
T ss_pred             cCCCCCCEEECCCCccCCcCChHHhcccchhhhhccccccccccccccccccccccccccccccccchhhhccccccccc
Confidence            88888888887765321000                                                            


Q ss_pred             ---ecccccCCCCCCCCCCccEEEEecCCCcceecccchhhcccCCcEEEEecCCCcceeeeCcCceecccCCCcceEec
Q 006185          478 ---IHATTSTSSPTPSLGNLVSITIRGCGKLRNLFTTSMVKSLVRLESLEVSSCPTLQEIIMDDEGEVGLQGASTKKITF  554 (657)
Q Consensus       478 ---~~~~~~~~~~~~~~~~L~~L~i~~c~~L~~l~~~~~~~~l~~L~~L~i~~C~~l~~~~~~~~~~~~l~~~~~~~~~~  554 (657)
                         ..+....+..+..+++|+.|+++++. ++...|.. ++.+++|+.|+++++.--..+|             .....+
T Consensus       615 l~~~~~~g~~~~~~~~l~~L~~LdLs~N~-l~g~ip~~-l~~l~~L~~L~Ls~N~l~g~ip-------------~~l~~L  679 (768)
T 3rgz_A          615 ITSRVYGGHTSPTFDNNGSMMFLDMSYNM-LSGYIPKE-IGSMPYLFILNLGHNDISGSIP-------------DEVGDL  679 (768)
T ss_dssp             TTSCEEEEECCCSCSSSBCCCEEECCSSC-CBSCCCGG-GGGCTTCCEEECCSSCCCSCCC-------------GGGGGC
T ss_pred             cccceecccCchhhhccccccEEECcCCc-ccccCCHH-HhccccCCEEeCcCCccCCCCC-------------hHHhCC
Confidence               00111224456667889999998875 44333433 5788999999999886433443             223357


Q ss_pred             cccCeeEcCcCCCccccccCCCcceeeccccceeeeccCCCcceecCCCccccceeceeEeccceeeccCchhHHHHHHH
Q 006185          555 PSLFSIKLCDLGSLTCFSSSGLHATVEFLALEALQIIDCPGMKTFGYGNQLTPKLLKGVEFGYCKYCWTGNLNHTIQQYV  634 (657)
Q Consensus       555 ~~L~~L~l~~c~~l~~l~~~~~~~~~~~~sL~~L~i~~C~~l~~lp~~~~~l~~~L~~L~i~~C~~l~~~~l~~~l~~~~  634 (657)
                      ++|+.|+++++.--..+| ..+.   .+++|++|++++++--..+|.+..  ..++....+.++|.+-...+    ..|.
T Consensus       680 ~~L~~LdLs~N~l~g~ip-~~l~---~l~~L~~L~ls~N~l~g~iP~~~~--~~~~~~~~~~gN~~Lcg~~l----~~C~  749 (768)
T 3rgz_A          680 RGLNILDLSSNKLDGRIP-QAMS---ALTMLTEIDLSNNNLSGPIPEMGQ--FETFPPAKFLNNPGLCGYPL----PRCD  749 (768)
T ss_dssp             TTCCEEECCSSCCEECCC-GGGG---GCCCCSEEECCSSEEEEECCSSSS--GGGSCGGGGCSCTEEESTTS----CCCC
T ss_pred             CCCCEEECCCCcccCcCC-hHHh---CCCCCCEEECcCCcccccCCCchh--hccCCHHHhcCCchhcCCCC----cCCC
Confidence            899999999975444667 6665   678999999999866666886652  35566677778886643222    2688


Q ss_pred             HhhhhhhHHHhhhcCCC
Q 006185          635 YNEKKIWEKQAMKSGIS  651 (657)
Q Consensus       635 ~~~~~~~~~i~~ip~v~  651 (657)
                      ...+++|++|+|+|.+.
T Consensus       750 ~~~~~~~~~~~~~~~~~  766 (768)
T 3rgz_A          750 PSNADGYAHHQRSHHHH  766 (768)
T ss_dssp             SCC--------------
T ss_pred             CCccCCCCCCCCccccC
Confidence            88899999999999764



>3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Back     alignment and structure
>3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Back     alignment and structure
>3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Back     alignment and structure
>3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Back     alignment and structure
>2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>4g8a_A TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, immune system; HET: NAG LP4 LP5 DAO MYR KDO; 2.40A {Homo sapiens} PDB: 3fxi_A* Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Back     alignment and structure
>3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Back     alignment and structure
>3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Back     alignment and structure
>3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Back     alignment and structure
>3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Back     alignment and structure
>3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Back     alignment and structure
>1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Back     alignment and structure
>1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Back     alignment and structure
>3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Back     alignment and structure
>2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Back     alignment and structure
>2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Back     alignment and structure
>1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Back     alignment and structure
>3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Back     alignment and structure
>2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Back     alignment and structure
>3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Back     alignment and structure
>1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Back     alignment and structure
>1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Back     alignment and structure
>3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Back     alignment and structure
>4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Back     alignment and structure
>1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>4glp_A Monocyte differentiation antigen CD14; alpha beta BENT solenoid, LRR, lipopolysaccharide, serum, CD leucine-rich repeat, pattern recognition; 4.00A {Homo sapiens} Back     alignment and structure
>2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Back     alignment and structure
>4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Back     alignment and structure
>3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Back     alignment and structure
>2ast_B S-phase kinase-associated protein 2; SCF-substrate complex, LRR, cell cycle, protein turnover COM ligase-ligase inhibitor complex; HET: TPO; 2.30A {Homo sapiens} SCOP: a.158.1.1 c.10.1.3 PDB: 2ass_B 1fqv_A* 1fs2_A Back     alignment and structure
>2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Back     alignment and structure
>3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Back     alignment and structure
>4b8c_D Glucose-repressible alcohol dehydrogenase transcr effector; hydrolase-cell cycle complex; 3.41A {Saccharomyces cerevisiae S288C} Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Back     alignment and structure
>1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Back     alignment and structure
>3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Back     alignment and structure
>3sb4_A Hypothetical leucine rich repeat protein; LRR, right-handed beta-alpha superhelix, leucine-rich repeat structural genomics; HET: MSE PG4; 1.99A {Bacteroides thetaiotaomicron} Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fdw_A Leucine rich hypothetical protein; putative cell surface protein, BIG3 domain, LRR domain, STRU genomics; 2.05A {Bacteroides ovatus} PDB: 4fd0_A Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>4fs7_A Uncharacterized protein; leucine-rich repeats, protein binding, extracellular protein structural genomics; HET: MSE; 1.19A {Bacteroides ovatus} Back     alignment and structure
>3un9_A NLR family member X1; leucine rich repeat (LRR), antiviral signaling, MAVS, TRAF6, UQCRC2, immune system; 2.65A {Homo sapiens} Back     alignment and structure
>2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>3e4g_A ATP synthase subunit S, mitochondrial; leucine-rich repeat, CF0, hydrogen ION transport, inner membrane, ION transport, membrane, mitochondrion; 0.96A {Bos taurus} PDB: 3e3z_A 3dze_A 3e2j_A Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>4gt6_A Cell surface protein; leucine rich repeats, putative protein binding, extracellula protein, structural genomics; HET: MSE; 1.80A {Faecalibacterium prausnitzii a2-165} Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>1io0_A Tropomodulin; LRR protein, right-handed super-helix, protein binding; 1.45A {Gallus gallus} SCOP: c.10.1.1 Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>3rw6_A Nuclear RNA export factor 1; retroviral constitutive transport element (CTE), RNA recogni motif (RRM); HET: GTP CCC; 2.30A {Homo sapiens} PDB: 3rw7_A 1koo_A 1koh_A 1ft8_A 1fo1_A Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>4h09_A Hypothetical leucine rich repeat protein; two LRR_5 domains, PF13306 family, structural genomics, JOIN for structural genomics, JCSG; 2.50A {Eubacterium ventriosum} Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>3rfe_A Platelet glycoprotein IB beta chain; platelet surface receptor, GPIX, cell adhesion; HET: NAG; 1.25A {Homo sapiens} PDB: 3rez_A* Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure
>1pgv_A TMD-1, tropomodulin TMD-1; structural genomics, PSI, protein structure initiative, southeast collaboratory for structural genomics secsg; 1.80A {Caenorhabditis elegans} SCOP: c.10.1.1 Back     alignment and structure

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST ?

ID ?Alignment Graph ?Length ? Definition ? E-value ?
Query 657
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 4e-11
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 7e-04
d2omza2384 c.10.2.1 (A:33-416) Internalin A {Listeria monocyt 0.001
d1xkua_305 c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 2e-08
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 1e-05
d1jl5a_353 c.10.2.6 (A:) Leucine rich effector protein YopM { 6e-05
d2astb2284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 3e-04
d2astb2284 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 8e-04
d1ozna_284 c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept 0.002
d1z7xw1460 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( 0.003
d1a9na_162 c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom 0.003
d1xwdc1242 c.10.2.7 (C:18-259) Follicle-stimulating hormone r 0.004
d1h6ua2227 c.10.2.1 (A:36-262) Internalin H {Listeria monocyt 0.004
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure

class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]
 Score = 62.7 bits (151), Expect = 4e-11
 Identities = 34/182 (18%), Positives = 70/182 (38%), Gaps = 28/182 (15%)

Query: 6   ELKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDL 65
           ++ D   +    +L  +SL  N + ++        L  L L  N +  +      G+  L
Sbjct: 208 QISDITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAP--LSGLTKL 265

Query: 66  KVLDLGGIRMVSPPSSLSF---------------------LSNLRTLRLDYCNHLPDLSL 104
             L LG  ++ +                            L NL  L L + N++ D+S 
Sbjct: 266 TELKLGANQISNISPLAGLTALTNLELNENQLEDISPISNLKNLTYLTLYF-NNISDISP 324

Query: 105 IGELSGLEILDLSKSDVNEIPVSFGRLSHLRLLDLTDCYNLELIPPGVLSRLRKLEELYM 164
           +  L+ L+ L  + + V+++  S   L+++  L        +L P   L+ L ++ +L +
Sbjct: 325 VSSLTKLQRLFFANNKVSDVS-SLANLTNINWLSAGHNQISDLTP---LANLTRITQLGL 380

Query: 165 SH 166
           + 
Sbjct: 381 ND 382


>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 Back     information, alignment and structure

Homologous Domains Detected by HHsearch ?

ID ?Alignment Graph ?Length ? Definition ? Probability ?
Query657
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.87
d2omza2384 Internalin A {Listeria monocytogenes [TaxId: 1639] 99.84
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.79
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.78
d1p9ag_266 von Willebrand factor binding domain of glycoprote 99.77
d1xkua_305 Decorin {Cow (Bos taurus) [TaxId: 9913]} 99.75
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.74
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.74
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.74
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.73
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.73
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.71
d2omxa2199 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.69
d1h6ta2210 Internalin B {Listeria monocytogenes [TaxId: 1639] 99.69
d1ogqa_313 Polygalacturonase inhibiting protein PGIP {Kidney 99.69
d1ozna_284 Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma 99.68
d1h6ua2227 Internalin H {Listeria monocytogenes [TaxId: 1639] 99.67
d1jl5a_353 Leucine rich effector protein YopM {Yersinia pesti 99.66
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.53
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.52
d2astb2284 Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa 99.49
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.49
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.46
d1a9na_162 Splicesomal U2A' protein {Human (Homo sapiens) [Ta 99.45
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.45
d1dcea3124 Rab geranylgeranyltransferase alpha-subunit, C-ter 99.45
d1xwdc1242 Follicle-stimulating hormone receptor {Human (Homo 99.44
d1w8aa_192 Slit {Fruit fly (Drosophila melanogaster) [TaxId: 99.35
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 99.22
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.12
d1m9la_198 Outer arm dynein light chain 1 {Green algae (Chlam 99.1
d2ifga3156 High affinity nerve growth factor receptor, N-term 99.07
d1z7xw1460 Ribonuclease inhibitor {Human (Homo sapiens) [TaxI 99.06
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 98.9
d2ifga3156 High affinity nerve growth factor receptor, N-term 98.9
d2ca6a1344 Rna1p (RanGAP1), N-terminal domain {Fission yeast 98.73
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 97.9
d1koha1162 mRNA export factor tap {Human (Homo sapiens) [TaxI 97.49
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 96.97
d1pgva_167 Tropomodulin C-terminal domain {nematode (Caenorha 96.96
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 96.71
d1io0a_166 Tropomodulin C-terminal domain {Chicken (Gallus ga 96.37
>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
class: Alpha and beta proteins (a/b)
fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix)
superfamily: L domain-like
family: Internalin LRR domain
domain: Internalin A
species: Listeria monocytogenes [TaxId: 1639]
Probab=99.87  E-value=4.9e-21  Score=195.66  Aligned_cols=198  Identities=21%  Similarity=0.261  Sum_probs=138.1

Q ss_pred             CCCCCCCCCCCCccEEEccCCCccccCCCCCCCCCcEEEecCCcCcCCCchhhcCCCCccEEEecCCcCCCCCccccCCC
Q 006185            7 LKDWPSINTFEDLTGISLMFNDIHEVPDGLECPKLQALFLQKNHLLVIPDPFFQGMKDLKVLDLGGIRMVSPPSSLSFLS   86 (657)
Q Consensus         7 l~~~~~~~~~~~L~~L~l~~~~~~~l~~~~~~~~L~~L~l~~~~~~~~~~~~~~~l~~Lr~L~L~~~~~~~lp~~~~~l~   86 (657)
                      +.+....+.+.++++|+++++.|++++....+++|++|++++|.+.++++  |+++++|++|++++|++..++. +++++
T Consensus        34 ~~~~~~~~~l~~l~~L~l~~~~I~~l~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~~-l~~l~  110 (384)
T d2omza2          34 VTDTVSQTDLDQVTTLQADRLGIKSIDGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP-LANLT  110 (384)
T ss_dssp             TTSEECHHHHTTCCEEECCSSCCCCCTTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG-GTTCT
T ss_pred             CCCccCHHHhCCCCEEECCCCCCCCccccccCCCCCEEeCcCCcCCCCcc--ccCCcccccccccccccccccc-ccccc
Confidence            33333445677899999999999888644488999999999999888876  7899999999999999887764 88999


Q ss_pred             CCcEEEccCCCCCCCCcccCCCCCCCEEEeeCCCCCccc--------------------ccccCCCCCCEEEccCCCCCC
Q 006185           87 NLRTLRLDYCNHLPDLSLIGELSGLEILDLSKSDVNEIP--------------------VSFGRLSHLRLLDLTDCYNLE  146 (657)
Q Consensus        87 ~L~~L~l~~~~~~~~~~~~~~l~~L~~L~l~~~~i~~lp--------------------~~i~~l~~L~~L~l~~c~~~~  146 (657)
                      +|++|+++++. .+..........+.......+.+..+.                    ..+.............+ .. 
T Consensus       111 ~L~~L~~~~~~-~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-  187 (384)
T d2omza2         111 NLTGLTLFNNQ-ITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSN-KV-  187 (384)
T ss_dssp             TCCEEECCSSC-CCCCGGGTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCCCGGGTTCTTCCEEECCSS-CC-
T ss_pred             ccccccccccc-ccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccccc-cc-
Confidence            99999998887 555555556666666666654433211                    11222333333333332 12 


Q ss_pred             CCchhHhhcCccCcEEEcccCccccccccccccccccchhhhcCCCCccEEEeecCCCccCCCCCCCCCccEEEEEEc
Q 006185          147 LIPPGVLSRLRKLEELYMSHSFCHWQFESEEDTRSNAKFIELGALSRLTSLHIDIPKGEIMPSDMSLPNLTSFSITIG  224 (657)
Q Consensus       147 ~~~~~~~~~l~~L~~L~l~~~~~~~~~~g~~~~~~~~~~~~l~~l~~L~~L~l~~~~~~~~~~~~~l~~L~~L~l~~~  224 (657)
                      ..... ...+++++.++++++.+.             ........++|+.|++.++.+..++....+++|+.+++.++
T Consensus       188 ~~~~~-~~~l~~~~~l~l~~n~i~-------------~~~~~~~~~~L~~L~l~~n~l~~~~~l~~l~~L~~L~l~~n  251 (384)
T d2omza2         188 SDISV-LAKLTNLESLIATNNQIS-------------DITPLGILTNLDELSLNGNQLKDIGTLASLTNLTDLDLANN  251 (384)
T ss_dssp             CCCGG-GGGCTTCSEEECCSSCCC-------------CCGGGGGCTTCCEEECCSSCCCCCGGGGGCTTCSEEECCSS
T ss_pred             ccccc-cccccccceeeccCCccC-------------CCCcccccCCCCEEECCCCCCCCcchhhcccccchhccccC
Confidence            22222 678889999998887553             12335667889999999988877766667788888887755



>d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Back     information, alignment and structure
>d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Back     information, alignment and structure
>d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Back     information, alignment and structure
>d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure
>d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} Back     information, alignment and structure